The US Food and Drug Administration (FDA) has voluntarily recalled 101 products made by Strauss Israel for potential contamination with Salmonella.
Elite chocolate, cakes, chewing gum, energy chocolate rice cakes, energy grain snacks, and wafers are among the products recalled by Strauss.
The Elite items were distributed to stores in California, Connecticut, Florida, New Jersey, and New York. Amazon, Fresh Direct, Passover.com, and other online stores have also carried kosher chocolates. The FDA's website has a complete list of the products that have been recalled.
The impacted chocolates and candies were created in a facility where Salmonella was discovered in both the liquid chocolate used in the goods and on production line equipment, according to the FDA. Customers who have purchased the products can return them for a full refund, and any merchant who carries them has been requested to remove them from the sale. In addition to the 101 products recalled in the US, the Canadian Food Inspection Agency (CIFA) has discovered 97 potentially contaminated products on the Canadian market.
According to the Strauss Group, they decided to act fully responsibly, not to take any risks, and remove all the factory products from the shelves.
The company also apologized to the Israeli public, customers, and retailers for the difficulty, while thanking them for their patience and vow9ng to get back to all inquiries.
The recall was initially limited to "more than a dozen types of chocolate and chocolate used as raw ingredients," but it was later expanded to include Elite-brand items. Two out of 270 chocolate goods tested positive for salmonella when Strauss tested samples from its plant. Since then, manufacturing at the company's plant has been temporarily halted.
According to the FDA, no illnesses have been linked to the recall in the United States. In Israel, 21 people who consumed the contaminated products developed symptoms that were compatible with salmonella, and the country's Health Ministry took samples from them.


Gold, Silver, and Platinum Rally as Precious Metals Recover from Sharp Selloff
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
US Judge Rejects $2.36B Penalty Bid Against Google in Privacy Data Case
JPMorgan Lifts Gold Price Forecast to $6,300 by End-2026 on Strong Central Bank and Investor Demand
Trump Threatens Aircraft Tariffs as U.S.-Canada Jet Certification Dispute Escalates
Boeing Secures New Labor Contract With Former Spirit AeroSystems Employees
Philippines Manufacturing PMI Hits Nine-Month High Despite Weak Confidence Outlook
Dollar Holds Firm as Strong U.S. Data, Fed Expectations and Global Central Bank Moves Shape Markets
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits
Hyundai Motor Lets Russia Plant Buyback Option Expire Amid Ongoing Ukraine War
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Asian Markets Slide as Silver Volatility, Earnings Season, and Central Bank Meetings Rattle Investors
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 



